Cargando…
Health Canada's Proposal to Accelerate New Drug Reviews
Health Canada is proposing to update its accelerated review pathways to get important new drugs into the market more quickly. To date, the two pathways that Health Canada uses have not demonstrated that they can identify therapeutically valuable new drugs. Drugs approved under the two pathways also...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Longwoods Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294445/ https://www.ncbi.nlm.nih.gov/pubmed/32538346 http://dx.doi.org/10.12927/hcpol.2020.26227 |